Inhibiting CREB binding protein (CBP)
US-12378242-B2 · Aug 5, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ericsson Anna patents
Ericsson Anna is listed as an inventor on 88 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ericsson Anna |
| Total patents | 88 |
| First publication | Mar 24, 2016 |
| Latest publication | Aug 5, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Inhibiting cyclic AMP-responsive element-binding protein (CREB)
US-12351577-B2 · Jul 8, 2025 · US
Inhibiting cyclic amp-responsive element-binding protein (creb)
US-2025188079-A1 · Jun 12, 2025 · US
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
US-12275715-B2 · Apr 15, 2025 · US
Activating pyruvate kinase R
US-12128035-B2 · Oct 29, 2024 · US
Activating pyruvate kinase R
US-12122778-B2 · Oct 22, 2024 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-12071440-B2 · Aug 27, 2024 · US
Treating sickle cell disease with a pyruvate kinase R activating compound
US-12053458-B2 · Aug 6, 2024 · US
Treating sickle cell disease with a pyruvate kinase R activating compound
US-11980611-B2 · May 14, 2024 · US
Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
US-2024150319-A1 · May 9, 2024 · US
Recent patents
Latest publications not already listed above.
Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitors
US-2024150349-A1 · May 9, 2024 · US
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2024083901-A1 · Mar 14, 2024 · US
Bromodomain inhibitors for androgen receptor-driven cancers
US-2024016795-A1 · Jan 18, 2024 · US
Activating pyruvate kinase R
US-11844787-B2 · Dec 19, 2023 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2023381151-A1 · Nov 30, 2023 · US
Bromodomain inhibitors for androgen receptor-driven cancers
US-11801243-B2 · Oct 31, 2023 · US
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
US-11787803-B2 · Oct 17, 2023 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-11649242-B2 · May 16, 2023 · US
Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
US-2023125739-A1 · Apr 27, 2023 · US
Inhibiting ubiquitin specific peptidase 9x
US-2023065368-A1 · Mar 2, 2023 · US
Activating pyruvate kinase r
US-2023055923-A1 · Feb 23, 2023 · US
Activating pyruvate kinase r
US-2022378756-A1 · Dec 1, 2022 · US
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
US-11498913-B2 · Nov 15, 2022 · US
Activating pyruvate kinase r
US-2022304987-A1 · Sep 29, 2022 · US
Inhibiting cyclic amp-responsive element-binding protein (creb)
US-2022213089-A1 · Jul 7, 2022 · US
Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitors
US-2022169647-A1 · Jun 2, 2022 · US
Inhibiting creb binding protein (cbp)
US-2022162207-A1 · May 26, 2022 · US
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
US-11292791-B2 · Apr 5, 2022 · US
Bromodomain inhibitors for androgen receptor-driven cancers
US-2022088005-A1 · Mar 24, 2022 · US
Activating pyruvate kinase r
US-2022087983-A1 · Mar 24, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Forma Therapeutics Inc | 82 |
| Novo Nordisk Healthcare Ag | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 61 |
| C07D471/04 | 47 |
| C07D487/04 | 34 |
| C07D401/12 | 31 |
| C07D519/00 | 29 |